Actively Recruiting

Age: 18Years +
FEMALE
Healthy Volunteers
NCT06918236

Association of Assisted Reproductive Technologies Parameters With the Perinatal Outcome

Led by Aristotle University Of Thessaloniki · Updated on 2025-04-09

12084

Participants Needed

6

Research Sites

217 weeks

Total Duration

On this page

Sponsors

A

Aristotle University Of Thessaloniki

Lead Sponsor

H

Hospital Universitario de Torrejón,Madrid

Collaborating Sponsor

AI-Summary

What this Trial Is About

The goal of this prospective cohort study is to examine how different parameters of assisted reproductive technologies (ART) are associated with the perinatal outcome in individuals with singleton or multiple gestations. The main questions it aims to answer are: Are ART pregnancies associated with a higher risk of: * Small for gestational age neonates? * Fetal growth restriction, either early- or late-onset? * Development of preeclampsia? * Stillbirth (intrauterine fetal death after 22 weeks not due to known anomalies)? * Are certain ART parameters-such as the type of fertilization (e.g., IVF vs. ICSI), embryo stage at transfer, use of fresh vs. frozen embryos, or ovarian stimulation protocols-more strongly associated with adverse outcomes? Are ART pregnancies associated with placental and umbilical cord abnormalities, including: * Placenta previa? * Vasa previa? * Single umbilical artery? * Velamentous or marginal cord insertion? Researchers will compare outcomes between pregnancies conceived through ART and those conceived spontaneously. Participants will: * Be individuals aged 18 or older undergoing routine first-trimester ultrasound between 11 and 14 weeks of gestation * Provide detailed medical, obstetric, and ART-related information * Undergo routine prenatal assessments, including ultrasound evaluations of fetal growth, Doppler studies, and placental characteristics * Have perinatal outcomes such as gestational age at birth, mode of delivery, birthweight, and complications systematically recorded Statistical models will be used to adjust for confounding factors such as maternal age, BMI, parity, and smoking. The aim is to better understand how ART and specific ART parameters may influence maternal and neonatal health and to improve counseling and clinical care for people using fertility treatments.

CONDITIONS

Official Title

Association of Assisted Reproductive Technologies Parameters With the Perinatal Outcome

Who Can Participate

Age: 18Years +
FEMALE
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Singleton or multiple pregnancies
  • Live fetus between 11 weeks 0 days and 13 weeks 6 days of gestation
Not Eligible

You will not qualify if you...

  • Known genetic anomalies diagnosed before or after birth
  • Major fetal defects diagnosed before or after birth, such as acrania, holoprosencephaly, megacystis, exomphalos, congenital heart defects

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 6 locations

1

University Hospital of Pleven

Pleven, Bulgaria, 5800

Not Yet Recruiting

2

Aristotle University of Thessaloniki

Thessaloniki, Central Macedonia, Greece, 54124

Actively Recruiting

3

Complejo Hospitalario Universitario de Canarias

Santa Cruz de Tenerife, Canary Islands, Spain, 38320

Not Yet Recruiting

4

Universidad Francisco de Vitoria

Madrid, Spain, 28223

Not Yet Recruiting

5

Hospital Universitario de Torrejón

Madrid, Spain, 28850

Not Yet Recruiting

6

Hospital Clínico Universitario "virgen de la Arrixaca"

Murcia, Spain, 30120

Not Yet Recruiting

Loading map...

Research Team

T

Themistoklis Dagklis

CONTACT

A

Antonios Siargkas

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here